Concepedia

Publication | Open Access

Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients

DOIFull Paper Access

129

Citations

21

References

2008

Year

William S. Weintraub, William E. Boden, Zugui Zhang, Paul Kolm, Zefeng Zhang, John A. Spertus, Pamela Hartigan, Emir Veledar, Claudine Jurkovitz, Jim Bowen,
Circulation Cardiovascular Quality and Outcomes

Abstract

The COURAGE trial did not find the addition of PCI to optimal medical therapy to be a cost-effective initial management strategy for symptomatic, chronic coronary artery disease.

References

YearCitations

Page 1